Brazilian Health Authorities widened the age range of potential recipients of the dengue vaccine as many doses were ...

The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...

Introduction State of the Art Dengue Vaccine Development Challenges in Dengue Vaccine Development Emerging Opportunities for Advancing Dengue Vaccine References State of the Art Dengue Vaccine ...

Under pressure to rebuild as sales of its blockbuster Lantus slide, Sanofi desperately needed the launch of its Dengue vaccine to run smoothly. But it hasn’t. Analysts had expected blockbuster ...

Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent ...

If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...

A study was conducted to assess the safety and tolerability of the tetravalent live-attenuated dengue vaccine Qdenga®, which received marketing approval in Germany in 2022. The study evaluated vaccine ...

The Pan American Health Organization (PAHO) has issued an epidemiological alert regarding the increased risk of dengue ...

Researchers have unveiled new insights into how weather influences the spread of dengue fever. Their study identifies ...

The Pan American Health Organization (PAHO) is warning that a dengue strain, the DENV-3 serotype, is on the rise in the Caribbean which could lead to a potential increase in cases of the disease. It ...

Progress is being made in primary prevention, with several candidate dengue vaccines in late phases of development as well as improved vector control measures. Additionally, new techniques for the ...